Selenium action in neuro-oncology (Q38243994)

31 August 2017

Selenium action in neuro-oncology (English)

1 reference

31 August 2017

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164034%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Eduard Yakubov

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164034%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Michael Buchfelder

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164034%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Ilker Y Eyüpoglu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164034%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

28 August 2014

1 reference

Biological Trace Element Research

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164034%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164034%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164034%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

246-254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25164034%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12011-014-0111-8

6 June 2020

exact match

0 references

cites work

Molecular actions of selenium in the brain: neuroprotective mechanisms of an essential trace element.

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Selenium and brain function: a poorly recognized liaison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Selenium and selenoprotein function in brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Mice lacking selenoprotein P and selenocysteine lyase exhibit severe neurological dysfunction, neurodegeneration, and audiogenic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Role of selenium-containing proteins in T-cell and macrophage function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Selenium supplementation restores innate and humoral immune responses in footrot-affected sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Neuroprotection induced by N-acetylcysteine and selenium against traumatic brain injury-induced apoptosis and calcium entry in hippocampus of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Thioredoxin reductase regulates angiogenesis by increasing endothelial cell-derived vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Malignant gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

From selenium to selenoproteins: synthesis, identity, and their role in human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Characterization of mammalian selenoproteomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Keshan disease, selenium deficiency, and the selenoproteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Diversity and functional plasticity of eukaryotic selenoproteins: identification and characterization of the SelJ family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Role for glutathione peroxidase-4 in brain development and neuronal apoptosis: specific induction of enzyme expression in reactive astrocytes following brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Molecular biology of glutathione peroxidase 4: from genomic structure to developmental expression and neural function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence-binding factor 1 is essential for embryonic brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Selenium and endocrine systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Antioxidant activity of sulfur and selenium: a review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Comparative analysis of selenocysteine machinery and selenoproteome gene expression in mouse brain identifies neurons as key functional sites of selenium in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Deletion of selenoprotein P alters distribution of selenium in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Molecular cloning of cDNA encoding a bovine selenoprotein P-like protein containing 12 selenocysteines and a (His-Pro) rich domain insertion, and its regional expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Neuronal and ependymal expression of selenoprotein P in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Absence of selenoprotein P but not selenocysteine lyase results in severe neurological dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Long isoform mouse selenoprotein P (Sepp1) supplies rat myoblast L8 cells with selenium via endocytosis mediated by heparin binding properties and apolipoprotein E receptor-2 (ApoER2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Plants, selenium and human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

The nutritional prevention of cancer: 400 mcg per day selenium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Selenium and risk of bladder cancer: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Inhibition of glioma cell line A-172 MMP activity and cell invasion in vitro by a nutrient mixture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Using chemopreventive agents to enhance the efficacy of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Selenium modulates oxidative stress-induced cell apoptosis in human myeloid HL-60 cells through regulation of calcium release and caspase-3 and -9 activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Selenium reduces mobile phone (900 MHz)-induced oxidative stress, mitochondrial function, and apoptosis in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Selenium and its relationship to cancer: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

DNA damage-mediated apoptosis induced by selenium compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Cyclophosphamide toxicity. Characterising and avoiding the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Melatonin ameliorates oxidative stress and reproductive toxicity induced by cyclophosphamide in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Testicular gametogenic and steroidogenic activities in cyclophosphamide treated rat: a correlative study with testicular oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Chemoprotective effect of lipoic acid against cyclophosphamide-induced changes in the rat sperm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Ebselen attenuates cyclophosphamide-induced oxidative stress and DNA damage in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Protective effect of Selenium nanoparticle against cyclophosphamide induced hepatotoxicity and genotoxicity in Swiss albino mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: Which one is the first observation as side effect of Cisplatin-induced toxicity in animal model?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

What is the place of carboplatin in paediatric oncology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Results of NCI-sponsored phase I trials with carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Chemotherapy-associated renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Selenium: from cancer prevention to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Toxicity and mutagenicity of selenium compounds in Saccharomyces cerevisiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

High dietary intake of sodium selenite induces oxidative DNA damage in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8

Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-014-0111-8